Skip to main content

Table 3 Drugs-resistance mutations according to HIV-1 subtypes and time of diagnosis in drug-naïve individuals from Paraná State, Brazil, 2010–2013

From: Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil

Sample identification

Diagnosis

HIV-1 subtype

NRTI mutations

NNRTI mutations

PI mutations

Resistance [23, 24]

L19

Chronic

B

–

K101E

–

EFV, NVP, ETR, RPV

L39

Chronic

C

–

K103 N

–

EFV, NVP

L97

Chronic

B

T215S

–

–

ZDV, d4T

L99

Recent

B

D67 N, T215S

–

–

ZDV, d4T, ABC

L150

Chronic

B

D67G

–

–

–

L156

Chronic

B

K70R

–

–

DDI, ZDV, d4T

L168

Chronic

C

–

G190E

–

EFV, NVP

M6

Chronic

C

–

K103 N

–

EFV, NVP

M18

Recent

B

–

K103 N

–

EFV, NVP

M19

Chronic

B

–

–

I54 V, V82A

IDV, NFV, LPV/r

  1. HIV-1 human immunodeficiency virus type 1, PR protease, RT reverse transcriptase, PI protease inhibitors, NRTI nucleoside analogue reverse transcriptase inhibitor, NNRTI non-nucleoside analogue reverse transcriptase inhibitors, EFV efavirenz, NVP nevirapine, ETR etravirine, RPV rilpivirine, ZDV zidovudine, d4T stavudine, ABC abacavir, DDI didanosine, IDV indinavir, NFV nelfinavir, LPV/r lopinavir/ritonavir